Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.43 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 6/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 5/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | ALPL | P05186 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 2/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16159768 | 0.91 | SCN9A (0.38) | SCN9ACHEK2KAT6APIK3CAKDR | |
| SCHEMBL16159929 | 0.91 | SCN9A (0.38) | SCN9ACHEK2KAT6APIK3CAKDR | |
| SCHEMBL16159882 | 0.90 | SCN9A (0.39) | SCN9ACHEK2KAT6APIK3CAKDR | |
| SCHEMBL16159896 | 0.90 | SCN9A (0.37) | SCN9ACHEK2KAT6APIK3CAKDR | |
| SCHEMBL16159669 | 0.89 | SCN9A (0.44) | SCN9ACHEK2KAT6APIK3CAIDO1 | |
| SCHEMBL17704447 | 0.88 | SCN9A (0.41) | SCN9ACHEK2BDKRB2IDO1TDO2 | |
| SCHEMBL16159916 | 0.86 | SCN9A (0.38) | SCN9ACHEK2PIK3CABDKRB2IDO1 | |
| SCHEMBL16159786 | 0.86 | SCN9A (0.41) | SCN9ACHEK2KAT6AKDRBDKRB2 | |
| SCHEMBL16159097 | 0.85 | SCN9A (0.42) | SCN9ACHEK2FEN1ALOX5APKAT6A | |
| SCHEMBL16159215 | 0.84 | SCN9A (0.39) | SCN9ACHEK2FEN1ALOX5APKAT6A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC CORPORATION (JP) | 2016-04-28 | — | — | US | disclosed |
| WO-2014163173-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | JNC株式会社 (JP) | 2014-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118598-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | HVCN1, VDAC1, SLC26A3 | SCN9A 1007/4885CHEK2 4800/4885FEN1 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.